Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Set To Show Strong Growth
Seeking Alpha
Tuesday, August 7, 2012 - 12:04pm
tags:
Arena Pharmaceuticals, Orexigen, Vivus, Belviq
Insmed Earnings: Transition is the Key Word, and Investors Don’t Like It
Wall St. Cheat Sheet
Tuesday, August 7, 2012 - 12:03pm
tags:
Insmed, earnings
MannKind 2Q loss narrows on year-ago payment
Yahoo/AP
Tuesday, August 7, 2012 - 12:01pm
tags:
MannKind, earnings
CytRx announces favorable results for clinical trial for aldoxorubicin
Yahoo/Fly on the Wall
Tuesday, August 7, 2012 - 11:54am
tags:
CytRx, aldoxorubicin, soft tissue sarcomas
What to Expect From Nektar Therapeutics
Motley Fool
Tuesday, August 7, 2012 - 11:53am
tags:
Nektar, earnings
Rigel Announces Second Quarter 2012 Financial Results
Yahoo
Tuesday, August 7, 2012 - 11:47am
tags:
Rigel Pharmaceuticals, earnings
Elan Shares Drop After Alzheimer’s Drug Development Halted
Bloomberg
Tuesday, August 7, 2012 - 11:44am
tags:
Elan, Pfizer, JNJ, bapineuzumab, Alzheimer's disease
3 Drugs Approved, but Only 1 Matters
Motley Fool
Tuesday, August 7, 2012 - 11:43am
tags:
FDA, drug approvals, Regeneron, Arcalyst, Eyelea, Novartis, Sanofi, Zaltrap
Pfizer charged with bribing overseas doctors
Marketwatch
Tuesday, August 7, 2012 - 11:28am
tags:
bribery, Pfizer, SEC
Pfizer-J&J Drop Alzheimer’s Drug Studies After Failure
Bloomberg
Monday, August 6, 2012 - 7:51pm
tags:
Alzheimer's disease, Pfizer, JNJ, bapineuzumab
K-V Pharma seeks Chapter 11 bankruptcy protection
Boston.com
Monday, August 6, 2012 - 12:38pm
tags:
bankruptcy, KV Pharmaceutical
Isis Reports Financial Results And Highlights For Second Quarter 2012
Yahoo
Monday, August 6, 2012 - 12:26pm
tags:
earnings, Isis Pharmaceuticals
Generic savings tell a different patent-loss tale
Fierce Pharma
Monday, August 6, 2012 - 12:24pm
tags:
generics, patents
1 Reason Endo Health Solutions May Be Headed for a Slowdown
Motley Fool
Monday, August 6, 2012 - 11:54am
tags:
Endo
NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Monday, August 6, 2012 - 11:53am
tags:
earnings, NeurogesX
Icahn says composition of Forest Labs' board has been detrimental
Yahoo/Fly on the Wall
Monday, August 6, 2012 - 11:52am
tags:
Carl Icahn, Forest Labs
Sanofi Reaches New 52-Week High
TheStreet.com
Monday, August 6, 2012 - 11:51am
tags:
Sanofi
Was MedImmune worth $15.6 billion?
Washington Post, DC
Monday, August 6, 2012 - 11:44am
tags:
MedImmune, AstraZeneca
4 Pharmaceutical Companies Moving On News
Seeking Alpha
Monday, August 6, 2012 - 11:13am
tags:
Oxigene, Biostar Pharmaceuticals, Pluristem Therapeutics, Cellceutix
Acorda: Volatility Expected On Upcoming Trial Results For Lower Ampyra Dose
Yahoo/Reuters
Monday, August 6, 2012 - 11:11am
tags:
AMPYRA, Acorda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.